Industry News
Boustead IPO Client Kairos Pharma, Ltd. (NYSE: KAPA) Announces Closing of $3.5 Private Placement
Boustead Securities, LLC (“Boustead”) IPO client Kairos Pharma, Ltd. (“Kairos Pharma” or the “Company”) (NYSE American: KAPA), a clinical-stage biopharmaceutical company developing cancer therapeutics designed to reverse cancer drug resistance
January 9, 2025